share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Jan 30 05:06
Summary by Moomoo AI
歌禮製藥有限公司於2024年1月30日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年1月30日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年1月30日，當日購回股份數目為750,000股，購回價格範圍為每股HKD 1.69至HKD 1.74，總付出金額為HKD 1,291,730。自普通決議案通過以來，公司在香港聯交所購回的股份總數達60,871,000股，佔已發行股份的5.5992%。公司確認，所有購回活動均按照香港聯交所主板上市規則進行，並且已收取全部款項，履行了所有上市先決條件。
歌禮製藥有限公司於2024年1月30日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年1月30日期間，進行了多次股份購回活動，但並未註銷這些股份。最新一次購回發生在2024年1月30日，當日購回股份數目為750,000股，購回價格範圍為每股HKD 1.69至HKD 1.74，總付出金額為HKD 1,291,730。自普通決議案通過以來，公司在香港聯交所購回的股份總數達60,871,000股，佔已發行股份的5.5992%。公司確認，所有購回活動均按照香港聯交所主板上市規則進行，並且已收取全部款項，履行了所有上市先決條件。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 30 JANUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and January 30, 2024, but did not write them off. The most recent repurchase took place on January 30, 2024. The number of shares repurchased on that date was 750,000 shares, with a repurchase price range of HKD 1.69 to HKD 1.74 per share, for a total payout of HKD 1,291,730. Since the adoption of the Ordinary Resolution, the Company has repurchased 60,871,000 shares on the Hong Kong Stock Exchange, representing 5.5992% of the issued shares. The Company confirms that all repurchases have been conducted in accordance with the listing rules of the HKEX Main Board and that all monies have been collected in compliance with all listing prerequisites.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 30 JANUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and January 30, 2024, but did not write them off. The most recent repurchase took place on January 30, 2024. The number of shares repurchased on that date was 750,000 shares, with a repurchase price range of HKD 1.69 to HKD 1.74 per share, for a total payout of HKD 1,291,730. Since the adoption of the Ordinary Resolution, the Company has repurchased 60,871,000 shares on the Hong Kong Stock Exchange, representing 5.5992% of the issued shares. The Company confirms that all repurchases have been conducted in accordance with the listing rules of the HKEX Main Board and that all monies have been collected in compliance with all listing prerequisites.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more